Complete Health Store
Complete Health Store

                                   DECEMBER  BLOG

                                                    U.S.                                                                  California

                                   CASES               DEATHS                                     CASES                 DEATHS       

December 2020    19,111,443            341,149                                  2,120,610                 24,241


2021   Timeline

January                  26,185,362             441,319                                3,310,949                  40,702

February                 28,602,101             513,137                                3,563,578                 51,953

March                    30,459,874              552,072                               3,668,277                  59,240

April                        32,225,012              574,280                              3,742,115                  62,078

May                        33,261,284              594,468                              3,789,227                  63,247

June                       33,624,871              603,966                              3,814,890                  63,569

July                         34,434,136              610,859                              3,903,052                  64,231 

August                   39,057,368*             638,700                              4,326,204                  65,757 

September            43,471,906              698,149                              4,720,860                  69,130

October                45,979,056              746,021                              4,915,796                  71,950


UPDATED WEEKLY - Last updated on 28 November 2021, 1:00 pm PST, John Hopkins Corona Virus Dashboard and Worldometer


Cases Worldwide

                            John Hopkins                                                    Worldometer

  • TOTAL CASES    -   261,406,293                      TOTAL CASES      -   261,686,345

Recovered     -                                               Recovered       -   236,345,106

  • TOTAL DEATHS  -     5,198,738                        TOTAL DEATHS    -       5,216,500


POPULATION - is 333,728,343 as of 28 November 2021, 1:00 pm PST, based on Census U.S. and World Population Clock.


Cases in the U.S.

  • TOTAL CASES      -   48,214,360                      TOTAL CASES         -     49,091,189

Recovered       -                                             Recovered          -     38,870,110

  • TOTAL DEATHS    -        776,586                     TOTAL DEATHS        -          799,360


Cases in California

  • TOTAL CASES       -   5,060,666                      TOTAL CASES         -        4,935,609

Recovered        -                                           Recovered          -             N/A

  • TOTAL DEATHS     -        74,152                      TOTAL DEATHS       -             74,393


The unemployment rate decreased in 27 states, increased in one, and remained unchanged in 36 states including Washington, DC, according to monthly data from the Bureau of Labor Statistics (BLS).


  • Nebraska and Utah reported September’s lowest unemployment rates, at 2.0% and 2.5% respectively. 
  • California and Nevada both had unemployment rates of 7.5%, the highest in the nation. Both states employ the most people in the trade, transportation, and utilities sector.
  • New York and New Jersey followed at 7.1%. New Mexico, Illinois, Connecticut, and Hawaii all reported rates above 6.5%. 
  • Massachusetts was the only state with an unemployment rate increase, rising 0.2 percentage points to 5.2% in September.


11/28/2021                   Cases (WHO)                     Deaths (WHO)                Recovered (WHO)

  • Texas**               -   4,319,671                              74,017                          4,163,010
  • Florida **           -    3,731,537                              61,147                          3,531,721
  • New York           -   2,796,237                              57,944                           2,331,291
  • Illinois                 -   1,784,900                               29,258                          1,649,136
  • Pennsylvania    -   1,725,902                               33,283                          1,566,786
  • Georgia**         -   1,659,491                               30,358                          1,379,555
  • Ohio                  -   1,677,741                               26,483                          1,550,522
  • N. Carolina**    -  1,524,078                               18,676                           1,477,280
  • Tennessee**     -   1,309,931                              16,967                           1,278,578
  • Arizona **         -  1,264,848                               22,229                           1,146,676


          **reporting information is limited, reduced testing and increased cases


 United States progress                                       Updated as of 28 November 2021, 1:00 pm PST

  • Doses Distributed                                                  572,190,175   
  • Doses Administered                                             454,447,737                79%
  • 1st dose administered                                        231,367,686                 70%
  • 2nd dose administered                                      196,168,756                 60%
  • Total population                                                 333,728,343

State Progress                                                       Updated as of 28 November 2021, 1:00 pm PST

   .                                                             1st dose                2nd dose           % fully Vaccinated      

  • California                                   30,886,780         24,8247,738                    62
  • Vermont                                         516,479                450,749                    72
  • Maine                                          1,093,735                698,553                    72
  • Connecticut*                             2,970,430             2,558,052                    71
  • Massachusetts                           5,856,929             4,883,284                    70
  • New York                                  15,075,041           13,268,116                    68  
  • Florida*                                     15,318,838           13,100,793                    60
  • Pennsylvania                           10,349,983*            7,430,988*                  58
  • Texas                                        18,474,428           15,793,073                    54
  • Alaska                                           455,580                395,164                    54       
  • Georgia                                     6,223,181             5,241,785                    49   
  • Tennessee*                                3,858,576             3,372,783                    49 
  • Mississippi**                                1,597,621            1,395,494                     46
  • Alabama                                   2,755,913            2,254,666                     45
  • West Virginia                                964,820               744,003                     41

*    Correction

**  Last on vaccine tracker







UPDATE - Thu, November 4, 2021, 7:43 PM

CDC Recommends Pfizer's COVID-19 Vaccine For Children Ages 5 to 11.  Families with young children finally have the news they've been waiting for: the Centers for Disease Control and Prevention officially recommends giving Pfizer's child-size dose of the coronavirus vaccine to children ages 5 to 11. This historic decision makes the vaccine available to 28 million children in the US.  Nearly the entire population of the nation is now eligible to receive the shot.


The CDC's advisory committee voted unanimously, spoke about their support of the vaccine, noting that their analysis shows how the benefits of the vaccine outweigh any risks for this age group.  This announcement comes after the Food and Drug Administration authorized Pfizer-BioNTech's vaccine for children ages 5 to 11 October 29.  


This expansion to children indicates parents may be able to protect their children following a tenuous start to the school year, which has seen ramped-up pediatric COVID-19 positivity rates due to the surge of the Delta variant among the unvaccinated.  BioNTech said it has laid out plans to seek approval for the vaccine in children between 6 months and 2 years old later this year.


Meanwhile, Moderna expects positive results from its own clinical trial of adolescents aged 12 to 17, and has dosage trials underway for children as young as 6 months old that they hope to submit by year's end.


FDA Authorizes Moderna and Johnson & Johnson Boosters, Allows People to ‘Mix and Match’ COVID-19 Vaccines.    Updated:   Oct. 29, 2021 12:02 p.m. PT.  The FDA authorized a Moderna vaccine booster for Moderna recipients age 65 years of age and older, and adults who are at high risk because of severe illness or exposure in their work setting.  Johnson & Johnson recipients age 18 and older will also be able to get a Moderna booster two months after being vaccinated, and will be eligible for Pfizer's booster too.  Those eligible can get their shots now. 


The CDC recommends the following people get their booster shot six months after they've been fully vaccinated with either Pfizer or Moderna:

  • 65 years and older
  • 18 or older who live in long-term care settings
  • 18 or older who have underlying medical conditions
  • 18 or older who work or live in high-risk settings


UPDATED 10/20 5:12 p.m. ET:  The FDA has approved booster shots for the Moderna and Johnson & Johnson vaccines.  The federal agency has authorized medical providers to allow people to receive a booster shot that’s different from the vaccine they initially received.


According the National Institutes of Health study on mixing vaccine booster shots presented to the FDA’s advisory panel, the “mix and match” approach looks to offer the most benefits to those who received Johnson & Johnson’s single-dose vaccine shot.


Those who first received the J&J shot then a J&J booster saw antibody levels increase four times.  People receiving the J&J shot and later receiving a Moderna booster saw their antibody levels increase 76 times over 15 days.  The Pfizer-BioNTech vaccine booster was also more effective in raising antibody levels of people who got the J&J vaccine and booster. 


“What the study shows is that regardless of what an individual received originally, getting boosted with one of the three vaccines that we evaluated, led to good antibody responses in each of the groups,” Dr. Robert Atmar of Baylor College of Medicine, an author of the study.



Many who have gotten the initial Pfizer shots six months ago are already getting a booster after the FDA authorized their use last month.   While Pfizer’s boosters are only for certain high-risk groups of Americans, Israeli officials credit wider booster use in their country to stemming the delta surge.


“There is no question in my mind that the break of the curve was due to the booster dose,” Alroy-Preis said in response to FDA advisers who noted that other countries have seen a lowering of delta cases without widespread booster use.


Pfizer says its vaccine is 90.7% effective against symptomatic Covid-19 in children ages 5 to 11

Pfizer indicated its vaccine is safe and 90.7% effective against symptomatic Covid-19 in children ages 5 to 11 in documents posted prior to a meeting with the US Food and Drug Administration’s vaccine advisers.


Pfizer/BioNTech are seeking FDA emergency use authorization, EUA, of a two-dose regimen of their 10-microgram dose for children ages 5 to 11.  The two doses would be administered three weeks apart.  If authorized, this would be the first Covid-19 vaccine for younger children. The Pfizer/BioNTech vaccine is approved for age 16 and older and an EUA for ages 12 to 15.


MODERNA VACCINE.  The FDA Panel Endorses Moderna COVID-19 Vaccine Booster Shots For Seniors, High-Risk Groups.  U.S. health advisers said some Americans who received Moderna’s COVID-19 vaccine should get a half-dose booster to bolster protection against the virus.


The panel of advisers to the Food and Drug Administration voted unanimously to recommend a booster shot for seniors, adults with other health problems, jobs or living situations that put them at increased risk for COVID-19.  Moderna indicates a single 50-microgram shot should be enough for a booster, half of the two 100-microgram shots.  Moderna indicated it would trigger fewer uncomfortable shot reactions such as fever and achiness, while also leaving more vaccine available for the global supply.


U.S. officials stress the priority is to get shots to the 66 million unvaccinated Americans who are eligible for immunization ― the most at risk of the delta variant.  “It’s important to remember, the vaccines provide strong protection against serious outcomes” - hospitalization and death - said FDA vaccine chief Dr. Peter Marks.


As the delta variant surged in July and August, those vaccinated had a 36% lower rate of “breakthrough” infections compared with those vaccinated longer ago, Moderna’s Dr. Jacqueline Miller told FDA’s advisers.


Moderna booster backed by advisory panel for elderly, at-risk.  A federal advisory committee unanimously supported booster shots of the Moderna COVID-19 vaccine for people 65 and older, as well as younger adults with certain medical conditions or jobs that put them at increased risk for infection.  The booster would be half the regular dose, given at least six months after the second shot.


Moderna's booster will be the second one to receive emergency use authorization if the decision is verified by a second advisory group and top officials at the Food and Drug Administration



Vaccine panel recommends J&J boosters after data says vaccine's effectiveness has 'headroom to improve': Live COVID-19 updates.  Johnson & Johnson's vaccine should be considered a two-dose vaccine rather than the one-and-done shot that received initial authorization, a federal panel decided.  The committee felt the 15 million Americans receiving the single dose of the "one and done" J&J vaccine would be substantially better protected with a second one. 


The unanimous decision from the Vaccines and Related Biological Products Advisory Committee came after real-world data showed J&J's one-shot vaccine is not as effective as the Pfizer and Moderna vaccines in real-world studies.


"Because the magnitude is lower than what would be desired – the estimates seen with the mRNA vaccines – there is headroom to improve the efficacy," said Dr. Penny Heaton, head of the vaccines global therapeutic area for Janssen Pharmaceuticals, a Johnson & Johnson company that developed the vaccine. 


Adding a second dose 2- to 6-months after the initial J&J shot would provide the same effectiveness as the mRNA vaccines without their fading protection, Heaton told the committee.  


FDA to convene independent panel on Merck's COVID pill.  The Merck antiviral pill,  molnupiravir, is set to be reviewed by an FDA panel on November 30th.  Merck officials said their antiviral pill is ready to be produced by the millions by the end of this year.  Internal data found the medication reduces hospitalizations by half.  Molnupiravir would be the first approved COVID-19 treatment in pill form and could be used globally to help mitigate symptoms for those who contract the virus.  Merck has already granted a royalty-free license to a nonprofit backed by the United Nations to manufacture the drug in 105 different nations. 


The Food and Drug Administration indicated it would convene a panel of outside experts to review the safety and efficacy data of Merck's pill to treat COVID-19 The group will meet Nov. 30, meaning Merck's pill likely won't receive authorization until December at the earliest.  Earlier this month, Merck said its trial data shows the experimental drug prevented half of severe coronavirus infections that would otherwise have sent people to the hospital.


A generic antidepressant might reduce COVID-19 symptoms in severe cases.   The antidepressant fluvoxamine, a generic, cheap drug, might reduce severe COVID-19 symptoms by up to a third, according to a trial conducted in Brazil.  The drug, a selective serotonin reuptake inhibitor, is typically used for obsessive compulsive disorder and depression, but can have effects on inflammation and clotting in the body.  The drug requires further study before officials would consider it for treatment of the virus.



  • The United States will allow vaccinated foreign nationals to enter the country starting Nov. 8 under a new international travel system.  Foreign national air travelers will need to be vaccinated and provide proof of vaccination to fly to the U.S.  Ahead of boarding, travelers will need to show a pre-departure negative test within three days of travel.


Only foreign nationals who have been fully vaccinated with a drug approved by the U.S. Food and Drug Administration or World Health Organization can enter the country.   That list does not include Covaxin.

  • Pennsylvania became the seventh state to report 1.5 million coronavirus cases.  States with the most cases include:
  • California - approximately 4.9 million;
  • Texas - approximately 4.2 million; and
  • Florida - more than 3.6 million.
  • Italy's strict vaccine requirements for all workers went into effect Friday. The rule requires all workers to show a health pass to get into their place of employment.  Police were out in force as protests against the rule were expected and could turn violent.
  • More than 100 workers at Los Alamos National Laboratory, the nuclear lab where the atomic bomb was created, are suing over a vaccine mandate that gives them until Friday to be vaccinated or fired.
  • Anyone age 12 and older will have to provide either proof of COVID-19 vaccination or a recent negative test to attend large events in the state of Washington starting Nov. 15.

CDC data shows how much better the vaccinated are faring.  In August, the unvaccinated were 11.3 times more likely to die of COVID-19 and 6.1 times more likely to test positive, the real-world data show.  On the worst reported week of deaths around Aug. 8, the unvaccinated died at a rate of 13.23 per 100,000, compared to Johnson & Johnson recipients at 3.14, Pfizer at 1.43 and Moderna at 0.73.


The vaccines also dramatically changed COVID-19 outcomes for the elderly compared to the unvaccinated.  The fully vaccinated, age 80 or older, were less likely to die of the disease than unvaccinated people in their 50s or early 60s.  The vaccinated of every age group were less likely to test positive than any age group of unvaccinated people.  The CDC says the data came from 16 governments representing about 30 percent of the population, from Florida to Wisconsin to Utah, as well as New York City.


Florida governor vows to challenge Biden's COVID vaccine mandate.  Florida will challenge the Biden administration's vaccine mandate in federal court, Gov. Ron DeSantis said Thursday, vowing that the pending requirement on businesses and hospitals "will go down." 


President Joe Biden's mandate expected this month would apply to hospitals that treat Medicare and Medicaid patients and employers with 100 or more employees.  Some Florida hospitals already have COVID-19 vaccine requirements in anticipation of the coming federal rule.


Pediatric COVID-19 vaccine likely widely available by November:   Officials In a private phone call, the White House urged governors to prepare to begin vaccinating elementary-age kids.

The Biden administration has purchased 65 million Pfizer pediatric vaccine doses in anticipation of authorization, according to a Health and Human Services official.  That is more than enough to fully vaccinate, two doses each, all 28 million 5 to 11-year-olds.

The Centers for Disease Control surveyed all states and 85% have said they are ready to go or are on track for enrolling providers to give COVID-19 vaccines to kids.  Five percent needed assistance with preparations, according to the HHS official.

Friday, October 15 is the deadline to have at least one shot in Philadelphia if you work in hospitals, long-term care, or work or study in higher education.  The Philadelphia Department of Public Health isn't seeing a huge rush for first-time shots instead, boosters are gaining steam.
Philadelphia reported about 24,500 booster shots this past week, up about 66% from the week prior.

On CNN, Dr. Anthony Fauci indicated the development of the Merck COVID anti-viral pill which could be on the market, pending FDA and CDC approval could reduce hospitalizations and death by 50%.  “It is promising but prevention is still the best policy.  It should not be a substitute for preventing infection in the first place, which is why we get vaccines."


COVID-19 live updates: CDC advising states to preorder Pfizer's vaccine for young children. 

SAN FRANCISCO (KGO) -- A surge in coronavirus cases has been reported in the Bay Area and across California as well as the country due in part to the emergence of the highly-contagious delta variant


Here are the latest developments on the respiratory illness in the Bay Area:

  • Oct. 15, 2021
  • 7:15 a.m. - CDC advising states to preorder Pfizer's vaccine for young children.   The U.S. Centers for Disease Control and Prevention is advising states to order Pfizer's COVID-19 vaccine doses for children ages 5 to 11 ahead of a vote on its authorization.  In planning documents posted by the CDC, the agency is advising states to order their doses in advance of the meeting, with preorders starting Oct. 20. 
  • 11 a.m. - FDA panel endorses booster shot for J&J COVID-19 vaccine.  A panel of U.S. health advisers has endorsed booster doses of Johnson & Johnson's single-shot COVID-19 vaccine.  The Food and Drug Administration panel said the booster should be offered at least two months after immunization but didn't suggest a firm time.
  • Oct. 14, 2021
  • 7:30 a.m. - Initial distribution of the Pfizer vaccine for children ages 5 to 11 years old will be based on a state's population of eligible children, according to the U.S. Centers for Disease Control and Prevention.
  • 11 a.m. - Contra Costa County will lift masking requirements on Nov. 1 in certain indoor settings where everyone is fully vaccinated.  Eligible settings are in controlled spaces not open to the general public, including offices, gyms and fitness centers, employee commuter vehicles, indoor college classes and organized gatherings in any other indoor setting, such as a religious gathering. 

Participating businesses, organizations and hosts must verify that all patrons, employees and attendees are fully vaccinated before allowing people inside their facilities not to wear face coverings.  There can be no more than 100 persons present at these facilities.


1:35p.m. - BART to require all employees get vaccinated against COVID-19 by Dec. 13.  (Bay City News) BART announced it will require all employees and contractors to be vaccinated against COVID-19 or prove their full vaccination status by Dec. 13 under an adopted policy, with an exemption for those who have a valid medical or religious exemption.

"By adopting this policy today, nobody is getting fired tomorrow," Li said. "No one is being forced to get the vaccine, but this policy states that being vaccinated is a condition of employment."  BART officials estimated that around 20 to 25 percent of BART's nearly 4,000 employees remain unvaccinated. 

  • Oct. 13, 2021
  • 6:55 a.m. - The Biden administration's mandate that employers with 100 or more workers require coronavirus vaccinations or institute weekly virus testing has moved one step closer to enforcement.  The Occupational Safety and Health Administration, or OSHA, has submitted text of the new rule to the OMB's Office of Information and Regulatory Affairs.
  • Oct. 12, 2021
  • 6:55 a.m. - COVID-19 misinformation could soon be declared a public health crisis.  The Contra Costa County board of supervisors says health misinformation has created "a culture of mistrust" and prolonged the pandemic.  900 people in the county have died and nearly 100,000 COVID cases have been reported.
  • Oct. 11, 2021
  • 7:15 a.m. - The first cruise ship has arrived in San Francisco since the pandemic began.  The last time a high-profile ship was here was March 2020.   Passengers had to be vaccinated and show a negative COVID test taken within two days.  
  • Oct. 8, 2021
  • 7:15 a.m. - Hospitalizations in the U.S. have dropped from 104,000 to about 69,000 over the last five weeks, according to federal data.  Daily COVID-19-related hospital admissions are also down nationally by 13.6% in the last week, according to federal data.
  • Oct. 7, 2021
  • 7:15 a.m. - United Airlines expects a travel surge, planning to provide 3,500 daily domestic flights in December, making it the largest schedule since the start of the pandemic.  Flight searches for the holidays are up 16%.
  • Oct. 6, 2021
  • 5:15 a.m. - The Food and Drug Administration could issue an emergency use authorization of the Pfizer vaccine for children ages 5 to 11 after Oct. 26.
  • Oct. 5, 2021
  • 6:25 a.m. - New COVID testing site opens exclusively for San Francisco Unified students and staff, Tuesdays and Fridays at the Crocker Amazon sports complex on Moscow Street.  You do not need an appointment to get tested.  The site can administer 150 tests per day for students and staff experiencing COVID symptoms or are considered in close contact with someone who has tested positive.
  • 3:00 p.m. - Bay Area counties consider easing indoor mask mandate.  San Francisco is set to ease its indoor mask mandate.  In a statement, the city's Health Department says it would consider low risk settings with low contact rates and places where people are fully vaccinated.
  • Oct. 4, 2021
  • 7:15 a.m. - COVID vaccine mandate takes effect for NYC teachers, staff. 
    Teachers and other school staff members were supposed to be vaccinated against COVID-19 when the bell rang Monday morning.   Mayor Bill de Blasio warned that unvaccinated school staffers would not be allowed to work Monday.  United Federation of Teachers indicated 97% of members had received at least one vaccine dose.   A similar mandate is set to go into effect in Los Angeles on Oct. 15.

  • Oct. 1, 2021
  • West Contra Costa Unified approves vaccine mandate.  A vaccine mandate has been approved for West Contra Costa Unified School District.  The school board voted to require students, employees, volunteers, board members, vendors and contractors to be vaccinated.  Eligible kids will be required to have one shot by November 15 and their second shot by December 15.  Officials say students with exemptions will be required to submit to rapid testing once every two weeks, in accordance with district policy.



U.S. COVID-19 vaccine rates up thanks to mandates; cases and deaths down -officials

Vaccination rates in the United States have risen by more than 20 percentage points after multiple institutions adopted vaccine requirements, while case numbers and deaths from the virus are down indicated Biden administration officials. White House response coordinator Jeff Zients told reporters, ‘77% of eligible Americans had received at least one shot of a vaccine.’


Vaccination rates went up when mandates were put into place by private businesses, healthcare systems, social institutions and state and local governments, he said in a briefing.

President Joe Biden's team has struggled to vanquish the coronavirus pandemic because a large swath of the U.S. population continues to resist taking safe and widely available vaccines.


The Administration announced policies requiring healthcare workers and federal employees to get COVID-19 vaccinations and push large employers to have their workers inoculated or tested weekly.  Federal rules to put the mandate into effect are being formalized.  Some states and large employers have mandated vaccines already.


"Despite the recent decrease in cases, most communities across the country are still experiencing substantial to high levels of community transmission," Walensky said.  "We absolutely need to stay focused on continuing to get COVID under control around the country, especially as we head into the fall and winter season" through masking and vaccinations, she said, “it was not time to let down the country's guard.”


The Occupational Safety and Health Administration, OSHA, was tasked with outlining rules for the vaccine mandate and the agency is expected to bring the mandate forward in the coming weeks.


CDC announces variant-finding testing program at major U.S. airports.  The program, limited to passengers on certain international flights coming into San Francisco, JFK and Newark International, is part of an effort to identify new variants from abroad amid fears of a vaccine-resistant strain entering the country.


Early detection will allow medical researchers to quickly begin testing how the new strains spread and react to the vaccines currently in use, officials say.  The CDC will be conducting the SFO monitoring program in collaboration with the XpresCheck COVID-19 testing company and Ginkgo Bioworks.


Greg Abbott's Vaccine Mandate Ban Comes as Texas Leads U.S. in Daily COVID Deaths

Texas Governor Gregg Abbott issued an executive order, EO, to prevent the enforcement of vaccine mandates in the state by any entity, including private businesses.  Abbott, a Republican, had previously issued an order prohibiting mask mandates and threatening fines for local government officials who tried to impose face mask requirements.  In a statement accompanying the order, Abbott added: "The COVID-19 vaccine is safe, effective, and our best defense against the virus, but should remain voluntary and never forced."


The new order comes as Texas leads the nation in average daily deaths due to COVID-19 and amid continuing vaccine hesitancy among a section of the U.S. population.  Data compiled by The New York Times shows that the average number of daily deaths from COVID-19 in Texas stands at 241.4.


Texas' average is significantly higher than the state with the next highest figure, Florida, which stands at 149.7 average daily deaths. That figure represents data from the seven days up to October 11.


How to Protect Yourself?  Getting vaccinated is your best bet!




Stay safe.  Mask.  Social distance.  Frequent hand washing.  Avoid crowds






Store Location

Complete Health Store

1756 N. Riverside Ave
Rialto, CA 92376

Phone: 909 879-1059
Fax     : 909 879-1043



Store Hours

Monday         10 am - 4:00 pm Tuesday         10 am - 4:00 pm

Wednesday  10 am - 4:00 pm

Thursday        10 am - 4:00 pm

Friday            10 am - 4:00 pm

Saturday           CLOSED

Sunday              CLOSED




D'Lightful Bites

10:30 am - 3 pm


Phone orders are encouraged. Large orders prior to 10:30 am


Deliveries not available during covid restrictions.

Ongoing Sales!!!

Stop in to check out all the items currently discounted for your personal resolutions.



Get Social with Us

Print | Sitemap
© Complete Health Store